We are live on
!
Find out more
Adage Capital Partners Portfolio holdings
AUM
$64.8B
1-Year Est. Return
42.7%
This Fund
S&P 500
This Quarter
Est. Return
+9.95%
1 Year Est. Return
+42.7%
3 Year Est. Return
+139.29%
5 Year Est. Return
+204.38%
10 Year Est. Return
+879.75%
AUM
$39.9B
AUM Growth
+$891M
(+2.3%)
Cap. Flow
-$1.96B
Cap. Flow
% of AUM
-4.91%
Top 10 Holdings %
Top 10 Hldgs %
26.01%
Holding
846
New
122
Increased
198
Reduced
391
Closed
98
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Johnson & Johnson
JNJ
|
+$171M |
| 2 |
Sensata Technologies
ST
|
+$145M |
| 3 |
Bristol-Myers Squibb
BMY
|
+$133M |
| 4 |
Amazon
AMZN
|
+$67.2M |
| 5 |
AbbVie
ABBV
|
+$65.5M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Otis Worldwide
OTIS
|
+$164M |
| 2 |
Ross Stores
ROST
|
+$110M |
| 3 |
Bank of America
BAC
|
+$94.4M |
| 4 |
Freeport-McMoran
FCX
|
+$92.4M |
| 5 |
Five Below
FIVE
|
+$89.9M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 23.1% |
| 2 | Healthcare | 19.47% |
| 3 | Consumer Discretionary | 12.58% |
| 4 | Financials | 11.29% |
| 5 | Communication Services | 8.51% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
426
QuidelOrtho
QDEL
$850M
| $16.5M | 0.04% |
+75,000
| New | +$16.7M |
|
427
Illinois Tool Works
ITW
$85.4B
| $16.4M | 0.04% |
+84,826
| New | +$16.1M |
|
428
CarMax
KMX
$8.3B
| $16.4M | 0.04% |
178,300
-106,100
| -37% | -$10.6M |
|
|
SNPR.U
429
DELISTED
Tortoise Acquisition Corp. II Units, each consisting of one Class A ordinary share and one-fourth of
SNPR.U
| $16.3M | 0.04% |
+1,500,000
| New | +$16.2M |
|
430
NVR
NVR
$17.1B
| $15.9M | 0.04% |
3,892
-8
| -0.2% | -$30.9K |
|
431
Healthpeak Properties
DOC
$14.7B
| $15.8M | 0.04% |
583,643
-19,500
| -3% | -$534K |
|
432
Cencora
COR
$61.5B
| $15.8M | 0.04% |
162,600
-5,300
| -3% | -$527K |
|
|
VNTR
433
DELISTED
Venator Materials PLC
VNTR
| $15.7M | 0.04% |
8,156,202
-1,000,000
| -11% | -$1.95M |
|
434
Nutrien
NTR
$30.9B
| $15.7M | 0.04% |
400,000
-800,000
| -67% | -$29.1M |
|
435
Extra Space Storage
EXR
$31.6B
| $15.5M | 0.04% |
145,300
+1,300
| +0.9% | +$134K |
|
436
Zimmer Biomet
ZBH
$18.4B
| $15.5M | 0.04% |
117,566
-129,265
| -52% | -$16.9M |
|
437
Nasdaq
NDAQ
$53.3B
| $15.5M | 0.04% |
379,140
-12,600
| -3% | -$537K |
|
438
Brown-Forman Class B
BF.B
$13.1B
| $15.5M | 0.04% |
205,432
+1,800
| +0.9% | +$129K |
|
439
Keysight
KEYS
$58.2B
| $15.4M | 0.04% |
156,025
-6,800
| -4% | -$668K |
|
|
DRE
440
DELISTED
Duke Realty Corp.
DRE
| $15.4M | 0.04% |
417,400
+3,700
| +0.9% | +$139K |
|
441
Nucor
NUE
$62.1B
| $15.1M | 0.04% |
336,435
-3,300
| -1% | -$146K |
|
442
Fortinet
FTNT
$117B
| $15.1M | 0.04% |
639,590
-24,500
| -4% | -$633K |
|
|
LVGO
443
DELISTED
Livongo Health, Inc. Common Stock
LVGO
| $15M | 0.04% |
+106,972
| New | +$13M |
|
444
Cardinal Health
CAH
$55.9B
| $15M | 0.04% |
318,600
-10,700
| -3% | -$549K |
|
445
Hormel Foods
HRL
$13.9B
| $14.9M | 0.04% |
303,946
-10,200
| -3% | -$512K |
|
446
Inspire Medical Systems
INSP
$1.72B
| $14.8M | 0.04% |
115,000
-25,000
| -18% | -$2.75M |
|
447
Nexstar Media Group
NXST
$5.96B
| $14.8M | 0.04% |
165,000
-110,000
| -40% | -$9.93M |
|
|
WBA
448
DELISTED
Walgreens Boots Alliance
WBA
| $14.7M | 0.04% |
409,697
-443,300
| -52% | -$17.3M |
|
449
Ameriprise Financial
AMP
$48.7B
| $14.7M | 0.04% |
95,268
-19,400
| -17% | -$2.99M |
|
450
General Dynamics
GD
$105B
| $14.6M | 0.04% |
105,710
-231,310
| -69% | -$34.2M |
|
Similar funds
Adage Capital Partners's Q3 2020 Portfolio in Review
As of Q3 2020, Adage Capital Partners held 846 positions worth $39.9B, up 2.3% from $39.1B the previous quarter. Its ten largest holdings account for 26% of the portfolio.
Adage Capital Partners withdrew a net $1.96B in Q3 2020, closing 98 positions and reducing 391 holdings. Its most notable exit was Pfizer, an estimated $60.9M position sold in full.
By sector, the portfolio is most concentrated in Technology at 23% of assets, up from 22% a quarter earlier, followed by Healthcare and Consumer Discretionary.
Against the trend, Adage Capital Partners opened a new position in Bristol-Myers Squibb worth $134M.
- Adage Capital Partners's largest Q3 2020 buy was Bristol-Myers Squibb: 2,215,804 shares worth $134M.
- Adage Capital Partners added most to Johnson & Johnson in Q3 2020, an estimated $171M increase.
- Adage Capital Partners's biggest Q3 2020 reduction was Otis Worldwide, cutting an estimated $164M.
- Adage Capital Partners fully exited Pfizer in Q3 2020, selling an estimated $60.9M.
- Adage Capital Partners's ten largest holdings make up 26% of its $39.9B portfolio in Q3 2020.
- Adage Capital Partners opened 122 new positions and closed 98 in Q3 2020.
- Adage Capital Partners's portfolio value rose 2.3% quarter-over-quarter to $39.9B.
Based on Adage Capital Partners's 13F filing for Q3 2020, filed 16 Nov 2020.